多模式分诊算法改善晚期卵巢癌初次减瘤术结局
纪念斯隆凯特琳癌症中心团队卵巢计划描述了一种多模式分诊算法,将晚期上皮性卵巢癌患者分流至初次减瘤术(PDS)或新辅助化疗(NACT)。研究纳入299例患者,根据可切除性(R)评分进行分诊,结果显示83%患者接受PDS,75%达到完全肉眼切除(CGR),94%达到理想减瘤。
要点
- R评分≤6为低风险,≥7为高风险,据此分诊至开腹PDS、腹腔镜评估或NACT。
- 低风险患者80%直接开腹PDS,19%先行腹腔镜评估;高风险患者70%先行腹腔镜评估。
- 算法使腹腔镜评估率达31%,次理想减瘤率仅6%,理想减瘤率达94%。
核心结论
- 多模式分诊算法使94%的晚期上皮性卵巢癌患者达到理想减瘤,次理想减瘤率仅6%。
研究设计与样本
- 回顾性队列研究,纳入2015年4月至2018年8月在纪念斯隆凯特琳癌症中心治疗的299例无PDS禁忌证的EOC患者,前瞻性计算R评分。
主要发现
- 299例中226例(76%)为低风险评分(≤6),73例(24%)为高风险评分(≥7)。
- 低风险组中181例(80%)直接开腹PDS,43例(19%)行腹腔镜评估(其中31例后续PDS,12例NACT),2例(1%)直接NACT。
- 高风险组中9例(12%)直接开腹PDS,51例(70%)行腹腔镜评估(其中28例后续PDS,23例NACT),13例(18%)直接NACT。
- 总体83%接受PDS,75%达到CGR,94%达到理想减瘤;算法实施后腹腔镜评估率31%,次理想PDS率6%。
关键数值与推荐
- 低风险评分定义为≤6,高风险评分定义为≥7。
- 分诊路径:低风险可开腹PDS或腹腔镜评估,高风险优先腹腔镜评估或NACT。
临床怎么用
- 临床可采用R评分联合腹腔镜评估对晚期EOC患者进行分诊,以降低次理想减瘤率。
局限性
- 单中心回顾性研究,样本量299例,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To describe outcomes using a multimodal algorithm to triage patients with advanced epithelial ovarian cancer (EOC) to primary debulking surgery (PDS) versus neoadjuvant chemotherapy (NACT). METHODS: All patients with EOC treated at our institution from 04/2015-08/2018 were identified. We included patients without contraindication to PDS who underwent prospective calculation of a Resectability (R)-score. A low risk score for suboptimal cytoreduction was defined as ≤6, and a high risk score ≥7. Patients were triaged to laparotomy/PDS, laparoscopic evaluation of resectability (LSC), or NACT depending on R-score. RESULTS: Among 299 participants, 226 (76%) had a low risk score and 73 (24%) a high risk score. For patients with a low risk score, management included laparotomy/PDS, 181 (80%); LSC, 43 (19%) (with subsequent triage: PDS, 31; NACT, 12); and NACT, 2 (1%). For patients with a high risk score, management included laparotomy/PDS, 9 (12%); LSC, 51 (70%) (with subsequent triage: PDS, 28; NACT, 23); and NACT, 13 (18%). Overall, 83% underwent PDS, with a 75% CGR rate and 94% optimal cytoreduction rate. Use of the algorithm resulted in a 31% LSC rate and a 6% rate of suboptimal PDS. CONCLUSIONS: The multimodal algorithm led to excellent surgical results; 94% of patients achieved an optimal resection, with a very low rate of suboptimal cytoreduction.
引用
- Straubhar AM, Filippova OT, Cowan RA, et al. A multimodality triage algorithm to improve cytoreductive outcomes in patients undergoing primary debulking surgery for advanced ovarian cancer: A Memorial Sloan Kettering Cancer Center team ovary initiative. Gynecol Oncol. 2020. PMID: 32518012. doi:10.1016/j.ygyno.2020.05.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。